— Know what they know.
Not Investment Advice

PGNY NASDAQ

Progyny, Inc.
1W: +8.0% 1M: +37.2% 3M: +17.7% YTD: -4.1% 1Y: +12.9% 3Y: -31.3% 5Y: -51.1%
$24.88
+0.19 (+0.77%)
 
Weekly Expected Move ±12.8%
$17 $20 $23 $26 $29
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Buy · Power 70 · $1.9B mcap · 72M float · 2.28% daily turnover · Short 54% of daily vol

Cash Flow Trends

Operating Cash Flow
$210M +17.4% ▲
5Y CAGR: +42.2%
Capital Expenditures
$18M -240.6% ▼
5Y CAGR: +77.8%
Free Cash Flow
$192M +10.4% ▲
5Y CAGR: +40.4%
Dividends Paid
$0 +0.0% ▲
Buybacks
$82M +72.8% ▲
Net Change in Cash
-$48M -174.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$66M$30M$62M$54M$59M
Depreciation & Amort.$1M$2M$2M$3M$5M
Stock-Based Comp.$0$0$0$128M$132M
Change in Working Capital-$51M-$59M-$17M-$12M$3M
Other Non-Cash Items$44M$115M$138M$16M$20M
Operating Cash Flow$26M$80M$189M$179M$210M
— Investing Activities —
Capital Expenditures-$2M-$3M-$4M-$5M-$18M
Acquisitions (Net)$0$0$0-$5M-$9M
Investment Purchases-$111M-$163M-$430M-$170M-$355M
Investment Sales$122M$123M$233M$377M$224M
Other Investing$0$0$0$0$0
Investing Cash Flow$9M-$44M-$201M$196M-$159M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0-$300M-$82M
Dividends Paid$0$0$0$0$0
Other Financing-$18M-$12M-$17M-$10M-$19M
Financing Cash Flow-$14M-$8M-$11M-$310M-$99M
Net Change in Cash$21M$29M-$23M$65M-$48M
Cash End of Period$91M$120M$97M$162M$114M
Free Cash Flow$24M$77M$185M$174M$192M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms